InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Artiva Biotherapeutics, Inc.

ARTV Clue Score30
United States Fiscal year ends December CIK 0001817241 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Fred Aslan
6 Oct 2026
Chief Executive Officer
Sold on a plan
23,463
$7.20
$168.88K
Fred Aslan
8 Sep 2026
Chief Executive Officer
Sold on a plan
23,429
$10.92
$255.75K
Fred Aslan
15 Dec 2025
President and CEO
Sold on a plan
3,187
$6.00
$19.12K
Fred Aslan
17 Nov 2025
President and CEO
Sold on a plan
6,375
$3.38
$21.52K
Fred Aslan
17 Oct 2025
President and CEO
Sold on a plan
25,500
$6.00
$153.00K
Fred Aslan
15 Aug 2025
President and CEO
Sold on a plan
25,500
$2.73
$69.58K
Show all 54 transactions →

What was left out

Form 4 filings counted 103
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 2
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 12,059,136
History held since 22 Jul 2024